Reducing POCT Device Costs: How RPA in Assembly Lines Benefits Distributors

For medical device distributors, the cost of POCT equipment is a critical factor. The adoption of Robotic Process Automation (RPA) in the manufacturing of rapid diagnostic test (RDT) readers is fundamentally changing the pricing structure. RPA streamlines the calibration of sensitive optical components, such as those used in Time-Resolved Fluorescence (TRF). This automated efficiency reduces the Bill of Materials (BOM) and labor costs, allowing manufacturers to offer highly competitive pricing to global distributors without sacrificing quality.

TL
Global Agent · Duebio (TiosBio) · 20+ Years in IVD
IVD industry veteran specializing in CRISPR Cas12/Cas13 detection, RAA isothermal amplification, lateral flow assays, microfluidic PCR, TRF immunoassays, and OEM/ODM IVD development for global distributors. Duebio is the international trade brand of TiosBio, a Chinese IVD manufacturer with 20+ years of experience.

Leave a Comment